Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

InCardia Inc.43 enrolled

Overview

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Heart Failure

Interventions

CorWatchDIAGNOSTIC_TEST

Non-invasive wearable monitor for the assessment of central venous pressure

Eligibility

Sex: ALLMin age: 21 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with NYHA class II-IV heart failure irrespective of ejection fraction * Patient is able to give consent Exclusion Criteria: * Severe tricuspid regurgitation * Mechanical ventilation * Patient is pregnant * Inability to access either of the patient's upper arms.

Locations (1)

University of California San Francisco

San Francisco, California, United States

Outcomes

Primary Outcomes

Agreement with right atrial pressure as measured by Swan Ganz catheter

Agreement between the CVP/RAP as assessed by the CorWatchTM method and the right arterial pressure (RAP) as measured by SG catheter

Time frame: During the right heart catheterization procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.